FDA Inspection
Avioq, Inc.Avioq, Inc. – FDA Inspection, Jan 13, 2017
Record Details
This FDA Inspection record concerns Avioq, Inc., with an inspection on January 13, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 4007711b-1cad-496b-9800-175a9760421a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1002599
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Avioq, Inc.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| May 14, 2026 | Not classified | Atlanta District Office | Blood and Blood Products |
| December 5, 2023 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 27, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 17, 2017 | Not classified | Atlanta District Office | |
| January 27, 2015 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Avioq, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.